Charles River Laboratories Announces Second-Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Charles River Laboratories (CRL) Tops Q2 EPS by 23c; Raises Guidance
August 4, 2021 7:08 AM EDTCharles River Laboratories (NYSE: CRL) reported Q2 EPS of $2.61, $0.23 better than the analyst estimate of $2.38. Revenue for the quarter came in at $914.6 million versus the consensus estimate of $880.65 million.
James C. Foster, Chairman, President and Chief Executive Officer, said, The strength of our leading, non-clinical... More
